SMURF2 and cancer: This intricate interplay between HSP-90, HSP-70, and the SMURF2-HIF1α axis underscores the necessity of carefully modulated therapies that target these pathways, aiming to overcome cancer cells’ adaptive mechanisms to achieve more durable responses.